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BACKGROUND: The increase of communicable and non- communicable diseases in Africa 
and the world today have been attributed to changes in human behaviour and lifestyles in 
generally susceptible individuals. Cameroonian lifestyle results in extreme risk of type 2 
diabetes. The prevalence of type 2 diabetes is predicted to increase extensively in sub- Saharan 
Africa, and predict to double in Cameroon, especially in the urban area, due to changes in human 
behaviour. 
OBJECTIVE: To provide baseline data that will contribute to the surveillance of diabetes in 
Cameroon and develop policies to prevent the occurrence of type 2 diabetes  
RESEARCH DESIGN AND METHODS: It was a population based, cross sectional study of 
1279 people. Data was collected using steps 1, 2 and 3 of the WHO STEPS instrument (Version 
1.3) for NCDs and their risk factor surveillance that was adapted for the Cameroon Burden of 
Diabetes (CAMBoD) project with respect to local specifications. The prevalence of diabetes and 
lifestyle factors was assessed according to standardized methods.  
RESULTS: The age standardized prevalence rate of diabetes and IFG was 9.0% and 6.8%, 
respectively. Generally, worsening glycaemic status was associated with increasing age, body 
mass index, systolic blood pressure and diastolic blood pressure. Overweight and obesity 
emerged as a strong independent risk factor for diabetes, irrespective of the measure used. 
Diabetes was more common in the female than the male p<0.005). The older age groups (46-55 
and 56+) had twice and thrice the risk of having diabetes, than the younger and the normal 
population (adjusted OR=3.1, p<0.001). Diabetes was found more in those who ate more 
servings of fruits and vegetables. Other lifestyles factors like physical activity and smoking was 
not a predictor of diabetes in this study, though revealing that smoker and those who are 
physically inactive has a higher risk of having diabetes. 
CONCLUSION: With the increasing associated lifestyle factors to diabetes mellitus in 
Cameroon, diabetes was found to be highly prevalent in middle and elderly Cameroonians. Our 
findings therefore highlight the need to adopt policies to reduce the burden of diabetes mellitus 
and obesity through health care services; special focus should be projected to women and special 
care should be taken for those who are in transition of lifestyle.  







Cameroon is a Central African nation on the Gulf of Guinea, bordered by Nigeria, Chad, the 
Central African Republic, the Republic of Congo, Equatorial Guinea, and Gabon. It is nearly 
twice the size of Oregon. Mount Cameroon (13,350 ft; 4,069 m), near the coast, is the highest 
elevation in the country. The main rivers are the Benue, Nyong, and Sanaga. She has both the 
sahelian and equatorial types of climate. Temperatures range between 15 and 40 degrees 
centigrade. The rainfall averages between 900 and 4 000mm. It has a land area of 469,440 km2 
and a total area of 475,440 km2. One third of the country is covered by forest (the south region), 
with savannah in the North. 
 
1. 2 Politics 
After a 1972 plebiscite, a unitary republic was formed out of East and West Cameroon to replace 
the former federal republic. Cameroon has the multiparty system of government with a 
Presidential politic system. The other powers are Legislative with National Assembly and 
Judiciary. The president appoints the Prime Minister and Head of Government who in 
consultation with the latter appoints the ministers. There are about 30 ministries including the 
ministry of public health.  
 
1.3 Population 
Cameroon's population was estimated at 18,060,382 million in 2007, growing by 2.2 % per year, 
with a literacy rate estimated to be 79% in 2003. The Official languages in Cameroon are French 








There are over 200 ethnic groups in Cameroon, categorized into a smaller number of tribes. Like 
nationalities, each tribe has stereotypical traits associated with it. Some are known to be tight 
with money, others like to party, and others are thought to be lazy. The ethnic groups are 
classified as; Cameroon Highlanders 31%, Equatorial Bantu 19%, Kirdi 11%, Fulani 10%, 
Northwest Bantu 8%, Eastern Nigritic 7%, other African 13% and  non-African less than 1%. 
 
1.5 Religion  
Cameroonians are generally religious (Catholic, Protestant or Muslim) but most follow a 
traditional religion as well. Belief in black magic is common (especially in cases of illness or bad 
luck). The Christians are 40%, Islam 20% and indigenous beliefs 40%.  
1.6 Economy 
Offshore oil deposits exploited since the early 1970s have made Cameroon one of the most 
prosperous nations in tropical Africa. Oil refining and the production of crude oil products lead 
the nation's industries. Before the advent of the petroleum business, agriculture was the country's 
economic mainstay, and it still contributes nearly a third of the country's gross domestic product. 
In the north, where cattle’s raising is the chief occupation, is the least economically developed 
part of Cameroon, whose regional disparities pose a major problem for the government. 
Cameroon remains one of the world's leading cocoa producers; coffee, bananas, palm products, 
tobacco, peanuts, and rubber. GDP/PPP $42.2 billion i.e. 2006 estimate; per capita income of 






Lifestyle change is the most common cause of development of type 2 diabetes in the developing 
countries. Comparing with other developing countries, who suffer from under nutrition, 
Cameroon suffers from over nutrition having a diet consisting of palm oil, corn flower products 
and red meat (1). Food intake in Cameroon is based on three meals daily. The diet in rural areas 
is based on traditional staple foods, while that of the urban population incorporates more modern 
foods (2-4).  A meals composition often depends on the economic situation of the household (3). 
Some of the staple foods in Cameroon includes white rice, plantains, corn in ground form called 
fufu, cassava, yams, cocoyam, banana and sweet potatoes. High fat intake in Cameroonian diet is 
due to the frequent use of palm oil. Many of the traditional sauces and dishes contain large 
amount of palm oil, which is the basic fat used in Cameroonian kitchen (5). Cultural tradition in 
Cameroon must also be blamed for the prevention of diabetes caused by obesity. Fattening your 
family is seen as taking good care of them. Having a fat wife is a prestige among friend and 
family. 
The rate of alcohol consumption in Cameroon is alarming and (alcohol marital sex) is the most 
common form of substance abuse in Cameroon. An existing data shows, the habitual diet in rural 
Cameroon contained more alcohol than the diet in urban Cameroon. There are situations, where 
individuals forsake paying children’s school fees because their money is spent on beer. The 
unrecorded alcohol consumption in Cameroon is estimated to be 2.6 litres pure alcohol per capita 
for population older than 15 for the years after 1995 (estimated by a group of key alcohol 
experts). WHO 2004 
 
1.8 Health care system 
 
The health services are centralized within the ministry of health. It has the overall responsibility 








Communicable and Non- communicable diseases are the most considered cause of morbidity and 
mortality worldwide. The increase of communicable and non- communicable diseases in Africa 
and the world today have been attributed to changes in human behaviour and lifestyles in 
generally susceptible individuals. It is clear that NCDs will continue to increase. This is driven 
by a combination of demographic change, increasing urbanization and associated changes in risk 
factor levels, like tobacco smoking, obesity and physical inactivity (6). The burden of non- 
communicable diseases have equally being noted to likely increase hugely over the coming 
decades and has been estimated will outstrips communicable diseases as a major cause of deaths 
in the year 2020s within the sub- Saharan Africa and most part of the world (7). The growing 
burden of cardiovascular risk factors led by diabetes mellitus and hypertension is the driving 
force of this disease pattern. In Cameroon, age-adjusted rates of blood pressure in urban areas 
has been showed to be greater than or equal to 160 mmHg systolic or 95 mmHg diastolic, and 
treatment of hypertension has risen from 5 percent in rural areas to 17 percent in urban ones (8) 
The weight of cardiovascular disease (CVD) on the world is enormous and growing, and most of 
the people affected are in developing countries (9). Reports in 2002 estimated that 29 percent of 
deaths worldwide (16.7 million deaths) were due to CVD and that 43 percent of global morbidity 
and mortality, measured in disability-adjusted life years (DALYs), was caused by CVD (10). 
Furthermore, 78 percent of global mortality and 86 percent of mortality and morbidity from 
CVD occurs in developing countries. By 2020 CVD will become the leading cause of the global 
health burden, accounting for 73 percent of total global mortality and 56 percent of total 
morbidity (10-12). Africa has not been spared of this global tide of CVD. In most African 
countries CVD is now the second most common cause of death after infectious disease, 
accounting for 11 percent of total deaths (13). CVD is a major cause of chronic illness and 
disability. Projections from the Global Burden of Disease Project suggested that from 1990 to 




undergoing an epidemiological transition with rising prevalence of cardiovascular diseases and 
risk factors. It is therefore, important to understand the association of modifiable and non- 
modifiable exposure variables with risk factors for chronic diseases in order to design 
appropriate intervention strategies. 
 
1.9.2 Diabetes Mellitus 
Diabetes mellitus is a group of metabolic disorder of multiple aetiology characterized by chronic 
hyperglycaemia with disturbances of carbohydrate, fat and protein metabolism, resulting from 
insulin secretion, insulin action or both (14). Diabetes mellitus, commonly referred to as 
diabetes, means "sweet urine." Elevated levels of blood glucose (hyperglycemia) lead to spillage 
of glucose into the urine, hence the term sweet urine. Normally, blood glucose levels are tightly 
controlled by insulin, a hormone produced by the pancreas. Insulin lowers the blood glucose 
level. When the blood glucose elevates (for example, after eating food), insulin is released from 
the pancreas to normalize the glucose level. In patients with diabetes mellitus, the absence or 
insufficient production of insulin causes hyperglycemia. Diabetes mellitus is also an important 
factor in accelerating the hardening and narrowing of the arteries (atherosclerosis), leading to 
strokes, coronary heart diseases, and other blood vessel diseases. Diabetes mellitus is a chronic 
medical condition, meaning it can last a lifetime. 
 
1.9.3 Global trend of diabetes mellitus 
Diabetes is now a worldwide epidemic and the rate of increase in its prevalence in developing 
and industrialized countries is alarming. It has been showed to be a well-established risk factor 
for CVD (15). The estimated prevalence of diabetes for all age- group worldwide was 2.8% in 
2000 and will be 4.4% in 2030, and is estimated in adults worldwide to be 4.0% in 1995 and to 
rise to 5.4% by the year 2025 (16). The prevalence is higher in men than women, but there are 
more women with diabetes than men. According to the recent global estimates of the World 
Health Organization, there will be 300 million people with diabetes by the year 2025 (17), with 




type 2 diabetes accounts for approximately 90% of all diabetes cases (18). It is known that 
physical inactivity, poor diet, family history, over weight and obesity, alcohol consumption, 
smoking are all associated risk factors to type 2 diabetes.  
In Sub- Saharan Africa, communicable diseases continue to have the greatest disease burden and 
it is estimated that by 2020 NCDs will outstrips communicable diseases as a cause of death (19). 
The prevalence of diabetes in African communities is increasing with ageing of the population 
and lifestyle changes associated with rapid urbanization and westernization. In conjunction with 
genetic susceptibility particularly in certain ethnic groups, type 2 diabetes is brought on by 
environmental and behavioural factors such as a sedentary lifestyle, overly rich nutrition and 
obesity (20-22). However, type 2 diabetes mellitus, hypertension, obesity, deficiencies and 
anaemia are partly related to food habits. 
The total number of people with diabetes is projected to rise from 170 million from 2000 to 366 
million to 2030 worldwide, in Africa from 7.020.000 to 18.234.000 and in Cameroon from   
70.000 to 171.000. 
 
1. 9.4 Situations of Type 2 diabetes in Sub­ Saharan­ Africa/ Cameroon 
Over the past century, diabetes mellitus has been considered a rare medical condition in Africa, 
according to Dr Cook in his note in 1901, as being uncommon and very fatal. However, 
epidemiological studies carried out in the 20th century, have provided a different picture, which 
has shown a global trend in the incidence and prevalence of diabetes mellitus in Africa 
population (23). The global epidemic of type 2 diabetes has not spared Sub- Saharan African 
countries, and its economic burden on the patients, family, community and nation is enormous 
(24). It is estimated that non-communicable diseases will contribute about 50% to the total 
disease burden in sub- Saharan Africa by 2020. Changes in lifestyle due to rapid urbanization, 
changes in food habits and physical activity levels and patterns may at least explain in part the 
ongoing transition (25-27). Cameroonian lifestyle results in extreme risk of type 2 diabetes, 
which as of today, 80% of diabetes cases in Cameroon are undetected (28). Once diabetes 




complications (renal failure, blindness, amputation and heart disease) that many developing 
countries are ill equipped to deal with. Modifying lifestyle is the best approach in the prevention 
of diabetes, than getting expensive medications. This is because lifestyle modification can be 
implemented locally, medications are often bought at high cost (29), sometimes drugs are not 
available and again inconsistency in drug administration. 
The prevalence of type 2 diabetes in Africa is about 2.5 percent, ranging from 0.8 percent in rural 
Cameroon (30) to 13.5 percent in Mauritius  (31). It is more frequent in South Africa and North 
Africa than in Central and West Africa, and it increases from rural to urban areas (32).  
 
1.10 Classification of Diabetes mellitus 
The type of diabetes assign to individual depends on the circumstances present at the time of 
diagnosis. Some diabetic individuals do not fit into single class. For example a person with 
Gestational diabetes may continue to be hyperglycemic after delivery and may be determined to 
have type 2 diabetes. Again a person who acquires diabetes because of large doses of exogenous 
steroids may become normoglycemic, once the glucocorticoids are discontinued, but then may 
develop diabetes later after recurrent episodes of pancreatitis. 
 
1.10.1 Type 1 diabetes (ß­cell destruction, leading to insulin deficiency) 
This is immune mediated diabetes. This type of diabetes, account for 5- 10% of those with 
diabetes. This was previously called insulin dependent diabetes or juvenile onset diabetes. It 
result from the autoimmune destruction of the ß-cell of the pancreas, which has multiple genetic 
predisposition and has also been said to be related to environmental factors, though still poorly 
defined. Idiopathic diabetes is a form of type 1 diabetes, and minority of patients being affected 







This type of diabetes, account for approximately 90-95% of those with diabetes. Was also called 
non- insulin dependent diabetes and adult onset diabetes. Those that fall here have insulin 
resistance and usually have relative rather than absolute insulin deficiency initially and 
throughout their lifetime. They don’t need insulin treatment to survive. There are probably many 
causes of this form of diabetes.  
Individuals with type 2 diabetes are also at a significantly higher risk for coronary heart disease, 
peripheral vascular disease, and stroke, and they have a greater likelihood of having 
hypertension, dyslipidemia and obesity. 
 
1.10.3 Gestational diabetes (GDM) 
This is defined as any degree of glucose intolerance with onset or first recognition during 
pregnancy. In united state, GDM affects 4% of all pregnancy, resulting to 135 thousand cases 
yearly. GDM represents nearly 90% of all pregnancies complicated by diabetes. 
 
1.10.4 Other specific types of diabetes 
Genetic defect of the ß-cell; Genetic defect in insulin secretion; Disease of the exocrine pancreas; 
Endocrinopathies; Drug or chemical induced diabetes; Infection; Uncommon forms of immune 








The clinical diagnosis of diabetes is usually prompted by symptoms like increased thirst and 
urine volume, recurrent infections, unexplained weight loss and in severe cases drowsiness and 
coma. High levels of glycosuria are usually present. 
   Glucose concentration, mmol l-1 (mg dl-1) 
   Whole blood Whole blood Plasma*  
     Venous Capillary Venous 
Diabetes Mellitus:       
 Fasting  >=6.1 (>=110) >=6.1 (>=110) >=7.0 (>=126) 
 or       
 2-h post glucose load >=10.0 (>=180) >=11.1 (>=200) >=11.1 (>=200) 
 or both    
Impaired Glucose Tolerance 
(IGT): 
      
 Fasting (if measured)  <6.1 (<110) <6.1 (<110) <7.0 (<126) 
 and    
 2-h post glucose load >=6.7 (>=120) and >=7.8 (>=140) and >=7.8 (>=140) and 
 <10.0 (<180) <11.1 (<200) <11.1 (<200) 
Impaired Fasting Glycaemia 
(IFG): 
      
 Fasting >=5.6 (>=100) and >=5.6 (>=100) and >=6.1 (>=110) and 
 <6.1 (<110) <6.1 (<110) <7.0 (<126) 
 and (if measured)    
 2-h post glucose load <6.7 (<120) <7.8 (<140) <7.8 (<140) 
* Corresponding values for capillary plasma are: for Diabetes Mellitus, fasting >=7.0 (>=126), 2-
h >=12.2 (>=220); for Impaired Glucose Tolerance, fasting <7.0 (<126) and 2-h >=8.9 (>=160) 
and <12.2 (<220); and for Impaired Fasting Glycaemia >=6.1 (>=110) and <7.0 (<126) and if 







Recently, researches have clearly shown that lifestyle intervention can reduce the risk of diabetes 
in those with impaired glucose tolerance; with weight reduction which appears to be the primary 
determinant of this effect. Weight loss can also improve glycemic control and cardiovascular risk 
factors in those with diabetes; however, the long-term impact of weight loss on cardiovascular 
morbidity and mortality is still under investigation (14;33-37). The increased of obesity has also 
contributed significantly to the prevalence of type 2 diabetes (38). Diabetes spending increases 
substantially in the presence of various Cardiometabolic risk factors (CMR) factors (e.g., obesity, 
hypertension, and dyslipidemia), independent of the presence of other chronic complications(39) 
 
1.10.7 Diabetes and HIV AIDs 
Recent studies have found type 2 diabetes in HIV positive patents. Fasting hyperglycaemia is 
associated with HIV protease inhibitors (PI) therapy. The pathogenesis of HIV-PI- associated 
diabetes, involves peripheral insulin resistance with insulin deficiency relative to 
hyperglucogonemia and body mass index (40). Metabolic alteration, including insulin resistance 
and diabetes mellitus has been found to be associated with antiretroviral (ART) therapy. Diabetes 
has been reported in 2 to 10% of people taking anti-HIV therapy, with prevalence growing as 
time on therapy increases. Recent studies have found that the risk of diabetes is four to five times 
greater in HIV-positive men on HAART (Highly Active Anti-retroviral therapy) compared with 
HIV-negative men, three times greater in HIV-positive women on HAART compared with HIV-
negative women, and that co-infection with hepatitis C appears to further increase the risk of 








The prevalence of type 2 diabetes is predicted to increase extensively in sub- Saharan Africa, and 
predict to double in Cameroon, especially in the urban area, due to changes in human behaviour. 
Cameroonian lifestyle results in extreme risk of type 2 diabetes, which as of today, 80% of 
diabetes cases in Cameroon are undetected (43). We therefore judge it necessary to conduct this 
study in view to provide baseline information and reference data, to policy makers in the 






















The objective here is to provide baseline data that will contribute to the surveillance of diabetes 




• To observe the prevalence of diabetes by gender and age group 
 
• To observe the association between lifestyle factors and the occurrence of diabetes 
mellitus 
• To analyze the association between measures of obesity 
• To study the prevalence of hypertension in Cameroonian adult population 
• To provide reference data on the prevalence and distribution of type 2 diabetes among 









Cross sectional study  
3.2 Study setting 
The study was conducted in the urban health District of Biyem-Assi, Yaoundé. This health 
district is currently being used as one of the site of the Cameroon Burden of Diabetes projects. 
This district is in Yaoundé, the capital city of Cameroon and its inhabitants are mostly office 
workers, commercial agents or students. It has a population of 422 522 inhabitants. 
 
3.3 Study Population 
The study population is Cameroonian men and women aged 25 years and above, who live in 
urban communities. They were recruited on the basis of a random sampling of households 
following a preliminary census of households in the study area. Home visits were organized for 
the collection of data by the researcher and certified field workers for data collection.  
 3.4 Selection Criteria of Health District 
Criteria for selection of Health District for study site included: belonging to one of the ecological 
zones of the country, geographical accessibility, being the most urbanized area of the ecological 
zone where the population density is highest and area where profound lifestyle changes have 
occured. The Biyem-Assi health district with specific characteristics was selected from one of 
the ecological zone for the study. 
 
3.5 Inclusion criteria 
Those included in the study were 25 years and above, and those who were willing to participant 
and comply with instruction of the study e.g. overnight fasting. It was voluntary participation and 






Pregnant women, individuals suffering from psychotic illness and those who were unable to walk 
unaided were not included in the study. 
 
3.7 Sample size calculation 
Using Epitable calculator in the Epi Info software, the sample size was calculated to achieve a 
precision of +/-1.5% within the study area, for an expected prevalence of diabetes of 4% and 
allowing a design effect of not more than 3.75 for a household clustered survey. This gave a 
required sample size of 2460. Assuming a non-response rate of about 10%, a sample of 2706 
individuals was therefore needed. However, owing to limited time and resources a sample size of 
1279 subjects was collected. Due to cost involved, research materials were insufficient for all the 
subjects, especially for the biochemical test. 
 
3.8 Sampling Technique 
The sampling scheme employed, was a multistage systematic sampling stratified by age group. 
Each sentinel site constituted a cluster and the health area within which the district hospital was 
implanted constituted the area frame. The households of the selected health area were considered 
the final sampling unit. A census had been conducted in the entire selected health area. All the 
households in the study site had been enlisted and all the adults aged 25 years and above 
registered. The total number of subjects within each age group was determined. This has been 
used to calculate the percentage contribution of each age group to the total population. This 
population percentage for each age group was then used to determine the number of households 
which was needed to achieve the desired sample size for each age group. The number of 
households obtained for each age group was then divided by the number of subjects in each 




age group sampling intervals was then used to obtain the households from which all the subjects 
were obtained.   
 
3.9 Definition of Household 
Household was defined as a group of people who share a common residence (live together) and 
partake in common meals. 
 
3.10 Piloting of tools 
 All the operational data collection tools were duly piloted in the site, the Biyem-Assi health 
district, and amended accordingly.  Evaluation indicators, in accordance with the STEPS 
instrument, included understanding of wordings of questions; clarity of questions; 




Data was collected using steps 1, 2 and 3 of the WHO steps instrument (Version 1.3) for NCDs 
and their risk factor surveillance that was adapted for the Cameroon Burden of Diabetes 
(CAMBoD) project with respect to local specifications. It is made up of three main sections: a 
self reported information questionnaire (step1), anthropometrical measurements (step2) and the 
biochemical measurements (step 3)(44). 
 
3.11.1 Questionnaire: Basic core, expanded and optional variables with regards to socio-
economic and demographic data, diabetes and its risk factors (tobacco, dietary habits and 




Education: The type of last educational institution attended was used, assigning four categories: 
none (attended no educational institution), primary (1–7 years of education), secondary (8–14 
years of education), and university (>14 years of education).  
Smoking: The classification used was non-smoker (has never smoked + ex-smoker) and smokers 
(current smokers).  
 
3.11.2  Anthropometrical  measurements: The clinical and anthropometrical 
measurements included weight, height, waist and hip girth and blood pressure (BP). These 
measurements were done using standardized methods (44-47). Body weight in light clothes was 
measured to the nearest 0.1 kg using a Sohenle mechanical weighing scale (Soehnle-Waagen 
GmbH & Co. KG, Wilhelm-Soehnle-Strabe 2, D-71540 Murrhardt/Germany) and the height to 
the nearest 0.5 cm using a portable, locally manufactured, stadiometer, with subjects, standing 
upright on a flat surface without shoes, the back of the heels and the occiput on the stadiometer. 
Waist circumference (WC), taken midway between the lowest rib and the iliac crest and hip 
circumference (HC) at the level of the greater trochanters was measured to the nearest mm using 
a flexible tape.  
 
 3.11. 2.1 Data on blood pressure 
Three readings of blood pressure, at 5 minutes interval were taken from each participant. 
Measurements were taken on a sitting position after 10 minutes rest, by the researcher and 
certified field workers according to a predefined protocol following American Heart Association 
(AHA) procedures, using electronic AND 0 78 Model UA-767 fully automatic, clinically 
validated digital BP monitor (A & D Company Limited Tokyo, Japan), with a suitable sized cuff 
(Small 9x18 cm, medium 12x23 cm and large 15×33 cm) at the forearm. Hypertension was 
defined as systolic BP (SBP) ≥ 140 mmHg and/or diastolic BP (DBP) ≥90 mmHg according to 




Treatment of high blood pressure (Ref JNC VII). Subjects with values of SBP and DBP under 
the defined limits but who reported taking antihypertensive treatment for at least two weeks 
before the survey onset were classified as hypertensives.  
 
3.11.2.2 Data on Obesity 
Body Mass Index (BMI), was calculated as the ratio of weight in kilograms over height in meters 
squared, [weight (kg)/height (m2)]. Four categories of BMI (≤ 20, 20-24.9, 25-29.9, and 
≥30kg/m2) were identified. Individuals with BMI≤ 20kg/m2 classified as underweight, healthy 
weight (BMI 20-25), overweight (BMI 25-29.9) and obese (BMI ≥30 kg/m2), respectively (48) 
WHO, 2003). Men with WC of < 94 were classified as normal weight, 94-101.9 overweight and 
≥102cm obese. Women were also classified in same categories of <80, 80- 87.9 and ≥88cm for 
normal weight, overweight and obese, respectively. Abdominal obesity was evaluated by the 
waist/hip ratio, by dividing WC by HC. Men with WHR <0.90, 0.90-0.99 and ≥1.0 were 
classified as normal weight, overweight and obese respectively, while for women, WHR were 
classified as <0.80, 0.80-0.84 and ≥0.85 (49).  
 
3.11.3 Biochemical measurements (data on diabetes)  
Every subject was visited at home between 5:30 a.m. and 9:00 a.m. on the day of appointment 
for the measurement of fasting capillary blood glucose using the HemoCue® B-Glucose data 
management analyser [HemoCue® B-Glucose photometer (photometer, 1995 #168)]. 
HemoCue®, is a diagnostic tool for measuring blood glucose. We used fasting capillary glucose 
with an abnormal FCG ≥ 110 mg/dl or 6.1 mmol/l FCG, to defined  diabetes, together with ≥5.6 







 Data entering took place, after the field work. The data was entered into EpiData version 3.1 and 




Quality assurance within the survey started with the recruitment of qualified field data collection 
staff. The pre-testing of the tools was secured. 
The appropriate training was provided to the field data collection staff in order to secure the 
quality of the data collected. Emphasis was laid on the anthropometrical measurements, BP 
taking and fasting capillary glucose procedures. Repeatability was assessed during the training. 
Refresher trainings were provided twice in the field to assure that the standards were up to date. 
The rigorous cold chain was maintained during the movement of the Microcuvet Haemocues, 
which is actually wet chemistry for obtaining fasting blood glucose, was a major quality measure 
for authentic data. Rigorous data management (crosschecking and validating forms and data 





Data are expressed as mean±2SD. Comparison was done by student t-test for continuous 
variables and χ2 –test for categorical variables. Logistic regression analyses were conducted to 
control the effects of potential confounding factors. All diabetic risk factors presented in table 1, 
were entered into regression model, with diabetes (0 =no, 1 =yes) as the dependent variables. 
Categorical data were expressed as frequency and percentages and compared by Chi-square test 
and non-parametric test in different subgroups or proportion in case of the violation of normal 




correlation coefficient, and adjusted for age. The analysis was done, using SPSS version 15. The 
statistical significance was set at P<0.05. All test performed was two tailed. 
 
3.11.9 Ethical issues 
All necessary ethical and administrative approval was obtained from the appropriate authorities 
before commencement of the study. Ethical clearance was obtained from Norwegian Ethical 
committee and National ethical committee of the Cameroon Ministry of public Health. 
Administrative clearance was obtained from the District Medical Officers and the Divisional 
Officer of the health districts.  
It was a project of free participation. All volunteers were provided with detailed information by 
letter about the study procedures and the risk and benefits involved. They had an opportunity to 
discuss with the researcher, if they require further informations and clarifications. All volunteers 
selected to participate in the study read and sign the informed consent form prior to commencing 
the study procedure. The volunteers had the right to withdraw at any stage of the study without 
giving any notification. The anthropometric and biochemical assessments were performed with 
care to avoid or limit possible uncomfortable and exhausting feelings.  The reason for carrying 
out the tests was explained, in order to secure any unexpected events. Data’s were handled 
confidentially without any personal identity. The project was carried out in accordance with the 










In this cross sectional study, a total of 1279 people aged 25 years and older from 595 households, 
participated in the study. One person withdrew from the study, because she changed her job and 
left the town. 
There were 530 (41.4%) males and 749 (58.6%) females. The mean age was 41.40± 13.2 years. 
In the study population 58% of the participants were married, 29.1% singles, 1.6% divorced, 
8.4% widow/widower, 0.6% separated, 1.5% cohabiting and the remaining 0.4% were those who 
were windows/widowers and divorcé(e) who remarried. 
Table 1 depicts the general characteristic of the study population. The mean ages were 42.5 and 
40.5 in men and women, respectively. The age range was in ten years interval. Among the 1279 
participants, 114 subjects were diagnosed to have type 2 diabetes during this study, with age 
standardized prevalence rate of 9.0% and impaired fasting glycaemia 6.8%. The overall 
prevalence of hypertension was 36.2% and obesity 23.9% (men 13.4% and women 31.4%). BMI, 
waist circumference, Hip circumference and fasting blood glucose were significantly higher in 
women than in men (p<0.05). Overweight and obesity was a common factor in the older age 
groups. Whereas the mean difference of systolic blood pressure and diastolic blood pressure 
were lower in women than men. Men were in general taller than the women. Mean levels of the 
anthropometric measurements, except for height and WHR were higher among women than the 
men (p<0.05). Men smoked more and was physically active than the women (p<0.001). There 







Table 1: Description of the study sample, Cameroon 2007 
      Characteristic of the study population by sex in urban Cameroonian aged ≥25years 
 
Characteristic                            Men                Women                                  Total   
Clinicala 
   
n                                                        530                      749                  1279 
  Age (years)                                          42.5±13.8                40.5±12.6**               41.4±13.2 
Body Max Index (kg/m2)                     24.7 ±4.9                 27.3±6.04**               26.2±5.7 
Waist circumference (cm)                   85.7±11.9                89.5±28.9**                87.9±23.5 
  Hip circumference (cm)                      96.4±9.92                104.7±20.1**              101.3±17.2 
Height (cm)                                         172.1±7.81              162.0±6.63**              166.2±8.72 
WHR                                                   0.89±0.09                 0.86±0.29*                 0.87±0.23  
Hypertension (mm/Hg) 
   SBP                                                  135.3±21.8              126.5±22.6**                130.2±22.7 
     DBP                                                  81.3±13.1               79.2±12.9**                 80.0±13.1 
FBG (mmol/l)                                      5.02±1.46               5.11±0.99*                  5.07±1.21           
IFG (mmol/l)%                                    30 (34.5)           57 (65.5)                    87   
Socio-demographicb        
Education level (%)                                                                                                                      
      None                                                97(18.3)                  196 (26.3) **                293 (23.1)             
    Primary                                            70(13.3)                  152 (20.4)                   222 (17.4)             
    Secondary                                        238 (45.1)               298(40)                       536 (42.1)                 University                                        122(23.1)                100(13.4)                    222 (17.5) 
Yearly income (million/CFA) (%) 
          <4 million                                     345(65.1)                573 (76.5)**                918 (71.8)                 
         >4 million                                    185(34.9)                176 (23.5)                   361 (28.2) 
Tobacco (%)        Non-smoker                                    294(55.5)               672 (89.7)                    966 (75.5) 
     Ex-smoker                                      161 (28.3)               67 (9.0) **                    228 (8.6)               
     Current smokers                             75 (16.2)                 10 (13.9)                      85 (15.9)                       
 
Diet intake (%) 
       Vegetable 0-3 days/week               311 (60.9)               439 (60.0)*                  750 (60.5)                                 
                      4-7days/week                199 (39)                  292 (39.9)                    491 (39.5)          
       Fruit        0-3 days/week              377 (77.0)               112 (22.9)                    871 (75.0)               
                      4-7days/week                494 (73.6)               178 (26.5)                    290 (25.0)     
  Physical activity (%) 
      0-100mins walk/day                      408 (77.0)                 636 (84.9) **              1044 (81.6) 
     < 100mins walk/day                       122 (23.0)                 113 (15.1) **              235 (18.4)                        
 
  
Mean with SD for clinical and percentages for socio-demographic data. *p= <0.05 and **p= <0.01 by 







4.2: Disease/ Risk factor prevalence 
114 subjects were diagnosed with type 2 diabetes during this study, with age standardized rate of 
9.0%, with mean value of 5.07±1.21. The prevalence of diabetes and impaired fasting glycaemia 
was (8.6% vs. 9.2%) and (5.7% vs. 7.6%) in men and women, respectively. Both the diabetes 
and impaired fasting glycaemia were found to be higher in women than the men, respectively. 
The overall prevalence of impaired fasting glycaemia was 6.8%.  
Age has an overall effect on diabetes. It was found to be the most important factor. Diabetes 
















mean fasting blood glucose














Table 2:      Prevalence of diabetes by sex and age group 
 
                            Men (n= 530)        Women (n= 749)          Total (n= 1279) 
 
Age groups  
 
25 -35                   10 (4.6)                       17 (5.0)                   27 (23.7) 
 
36 -45                   6 (6.4)                       16 (9.6)                    22 (19.3) 
 
46 -55                   13 (12.1)                       26 (17.3)                 39 (34.2) 
 
56+                       16 (15.2)                       10 (10.8)                 26 (22.8) 
 
Total                     45(8.6)                          69 (9.2)                   114 (9.0) 
 





Mean values of fasting blood glucose within age groups, systolic blood pressure, diastolic blood 
pressure, waist- hip-ratio, body mass index categories and tobacco consumption, are shown in 
table 3. Looking at the groups within the variables, the concentration of fasting blood glucose 
significantly increases with increasing age , body mass index (BMI), blood pressures (systolic 
and diastolic) and waist-hip-ratio (p<0.05). Women had a significantly higher blood glucose 
level at 35 - 55 years of age (p<0.05), while men had higher levels at a much older age (above 56 
years). Again, mean levels of blood glucose was significantly higher in women with high systolic 
and diastolic blood pressure (p<0.01). Meanwhile, the overweight and obese men had a higher 
blood glucose concentration, than the overweight and obese women. Men with higher waist-hip-
ratio (overweight and obese) had a higher blood glucose level than women. The same difference 






Table 3: Mean glucose concentrations (mmol/l) in different subgroups 
  
        
                                                 
Variables                                Men                             Women                  Total 
        n 530 749 1279 
        Age group (years)   
        25-35                                      4.79±0.80                 4.93±0.74 *               4.86±0.41               
       36-45                                      4.80±0.93                 5.10±0.81*                 4.95±0.87                      46-55                                      5.21±1.60                  5.49±1.53                  5.35±1.56 
       56+                                         5.50±2.36                 5.13±0.80                  5.31±1.58   
       Systolic BP                             0-140 (mmHg)                  4.96±1.46                 5.03±0.76**                 4.99±1.11 
           ≥140                                   5.16±1.47                 5.30±1.50                   5.23±1.48         Diastolic BP                           
            0-90 (mmHg)                     4.90±1.41                 5.06±0.87**                 4.98±1.14 
             ≥90                                    5.18±1.40                 5.57±1.36                   5.37±1.38 
       BMI 
           Underweight                         4.61±0.96                4.83±0.74**                 4.72±0.85 
           Normal                                4.91±1.30                4.95±0.69                    4.93±1.99 
            Overweight                          5.19±1.50                5.06±0.84                    5.12±1.17 
           Obese                                   5.40±1.40               5.37±1.32                    5.38±1.36  
       Waist-hip-ratio 
            Normal                               4.83±1.21                4.99±0.75**                 4.91±0.98 
             Overweight                         5.26±1.50                5.09±0.81                   5.17±1.15 
            Obese                                 5.31±2.08                5.18±1.17                    5.24±1.62 
        Smokers  
             Non-smokers                      5.02±1.56               5.11±1.0                     5.06±1.28 
              Ex-smokers                        5.02±1.33               5.09±0.63                    5.05±0.98 
             Current smokers                 5.05±0.78               4.81±0.59                    4.93±0.68 
                         
 BMI defined as 18.5-19.9 underweight, 20-24.9 as normal, 25-29.9 overweight and ≥ 30 
0bese. SBP was defined as 0-140 being normal and ≥ 140 as high; DBP 0-90 normal and ≥ 
90 high. Waist-Hip –Ratio, defined as normal, overweight and obese for men (<0.90, 0.90-
0.99 and ≥1) and women (<0.80, 0.80-0.84 and ≥0.85), respectively. * p< 0.05, p< 0.01 










4.2.2  Underweight,  Overweight  and  Obesity: Table 4 shows the distribution of 
overweight and obesity among the men and women. Based on body mass index, more than 50% 
of men and majority of women were either overweight or obese with 13.4% of men and 31.4% 
of women being obese. The prevalence of obesity showed considerable variation with age in 
both genders. 
Women had significantly higher Body Mass Index than the men (p<0.001), whereas men had a 
significantly lower BMI of < 25kg/m2 (p<0.001).  Therefore overweight and obesity were more 
prevalent among women.  
 










Variables        Men (n=530)            Women (n=749)        Total (n=1279)                   p    
Underweight            67 (12.6)                  64 (8.5)                    131(10.2)          < 0.001 
Normal                    238 (44.9)                218 (29.1)                   456 (35.7)               < 0.001   
Overweight              154 (29.1)               232 (31.0)                  386 (30.2) < 0.001 
Obese                      71 (13.4)                 235 (31.4)                 306 (23.9) < 0.001 
Total                        530 (41.4)               749 (58.6)                 1279    
BMI: Body Mass Index. Underweight defined as BMI 18.5-19.9 kg/m2, normal weight as BMI 








Table 5 depicts a variation in the distribution of obesity in different age groups. There was a 
significant difference in the measures of body mass index in each age group (p<0.001). in all the 
age groups, overweight and obesity was highly observed. Underweight was also higher at the 
youngest and oldest age group. 
 
Table 5: Distribution of overweight and obesity by age groups 
 
                            Underweight               Normal             Overweight              Obese                  
Age groups  
25-35                     57(10.2)                   239 (42.8)            161(28.8)               102 (18.2) **  
36-45                     24 (9.2)                     83 (31.7)              89 (34.0)                66 (25.2) **          
46-55                    25 (9.7)                      59 (22.9)              77 (29.8)               97 (37.6) **  
56+                       25 (12.5)                     75 (37.5)             59 (29.5)               41 (20.5) **     
Total                     131 (10.2)                  456 (35.7)            386 (30.2)            306 (23.9)   
BMI: Body Mass Index. Underweight defined as BMI 18.5-19.9 kg/m2, normal weight as BMI 
between 20-24.9, overweight as BMI between 25-29.9 and obesity as BMI ≥ 30kg/m2. *p= <0.05 and 







4.2.3: Prevalence of obesity by Body Mass Index, Waist circumference and Waist-Hip-
Ratio between genders and age groups. 
The distribution of overweight and obesity in the study population, based on Body Mass Index, 
Waist Circumference and Waist-Hip-Ratio are shown in table 6. Women always had a high 
prevalence of obesity, irrespective of the age. The prevalence of obesity showed significant 




women was large in the younger age group (25-35 years), where the ratio of prevalence of obese 
women to obese men was over >5.0 (35.5% versus 5.0%). Using BMI, the prevalence of obesity 
in men and women peaked within the age range of 46–55 year and then declined thereafter. This 
was more pronounced among the women. Using waist-hip-ratio provided the highest prevalence 
of obesity in men (27.1%) and women (75.3%). Waist circumference provided the lowest 

















Table 6: Prevalence of obesity by Body Mass Index, Waist circumference and Waist-Hip-
Ratio in Cameroonian adult population 
 
                                      BMI                                           WC                                 WHR 
 % %                  %          %                      %                 % 
Age groups    n      Overweight   Obese          Overweight   Obese          Overweight    Obese
       
Men 
25 – 35          221    24.0               10.0                   4.1                5.0                     9.5                7.2 
36 – 45          95    35.8               10.5       15.8             12.6                   31.6               9.5 
46 – 55          107    33.6               20.6      15.9               20.6                   46.7              19.6
56+               107    29.0               15.9                   20.6              17.8                   46.6              27.1 
Total             530    29.1        13.4                  11.9               12.1                 28.9              14.2 
Women 
25 – 35          338        32.0                 23.7                  22.8                35.5                     24.9             40.8 
36 – 45          167        32.9                 33.5                 18.6                 52.1                     25.7             46.1 
46 – 55           151       27.2                49.7                  17.9                 66.2                     25.8             53.0 
56+                 93          30.1                25.8                  30.1                49.5                     11.8             75.3 
Total              749         31.0                31.4                  21.8                47.1                     23.6             48.7      
 
BMI: Body Mass Index. Overweight was defined as BMI between 25- 29.9 and obesity as BMI 
≥30kg/m2 in men and women. WC: Waist Circumference. Overweight was defined based on WC 94- 
101.9cm and 80-87 in men and women, respectively and obesity based on WC ≥102 cm in men and ≥ 
88 cm in women. WHR: Waist-to-hip ratio was defined based on WHR 0.90-0.99 and WHR 0.80-0.84 





Figure 2 shows Pair-wise partial correlation between weight, BMI, WC, HC and WHR was 
investigated, after controlling for age. Weight, Body Mass Index, Waist Circumference and Hip 
Circumference were strongly correlated in both men and women, signifying that measures of 
obesity based on these parameters will provide comparable information’s. On the other hand 
Waist-Hip-Ratio shows a weaker correlation with others anthropometric measurements, and a 
negative correlation with Hip circumference.  




                                                                    Men                                                 Women   
Weight BMI WC HC WHR   
Weight - 0.84 0.77 0.77 0.24  
BMI 0.93 - 0.77 0.70 0.29 
 
 
WC 0.36 0.35 - 0.72 0.56  
HC 0.59 0.60 0.23 - -0.14  
WHR 0.04 0.02 0.86 -0.14 -  
 
 
All coefficients were significantly different (p< 0.05). WC (Waist Circumference in cm), HC (Hip 









4.2.5: Relationship between blood pressure, sex and age 
The prevalence of hypertension showed significant variation with age in both genders (table 7). 
Both men and women had significantly higher systolic and diastolic blood pressure. However, 
men had a significantly higher systolic (p<0.001). In both men and women, at age of 56 and 
above there is a lower prevalence of diastolic, but with a significantly higher prevalence of 
systolic blood pressure.  
 
Table 7. Percentage distribution of hypertensive and blood pressure by gender and age 
groups 
 
               
                              None hypertensive    hypertensive       SBP               DBP  
                                        (≤140/90)          (>140/90)   ( ≥ 140 )           ( ≥ 90)  
               Men 
                 25-35                  172 (77.8)            19 (8.6)          20 (9.8)          10 (4.5)                 36-45                 73 (77.7)              14 (14.9)        3 (3.2)            4 (4.3)     
               46-55                 52 (49.1)              26 (24.5)        21 (19.8)        7 (6.6)       
                 56+                    44 (41.1)              36 (33.6)        26 (24.3)        1 (0.9)   
 
   
              Women 
                   25-35                  299 (89.5)          14 (4.2)         5 (1.5)              16 (4.8)      
                 36-45                   117 (70.5)          26 (15.7)      13 (7.8)             10 (6.0)    
                 46-55                    83 (56.1)           35 (23.6)      19 (12.8)           11 (7.4)     








4.2.6: Obesity and hypertension: 
There was a significant difference, between body mass index and hypertension (p<0.05). Those 
with hypertension (>140/90) were more overweight and obese than those with high systolic and 
diastolic blood pressure. Among those with high blood pressure, there was a difference in the 
distribution of body mass index. Overweight and obesity was more in those with high systolic 
blood pressure (≥140), compare with diastolic blood pressure (≥90) 
 
Table 8: The distribution of BMI in Hypertensive subjects 
 
Variables             underweight       normal         overweight           obese        total 
   
 
Hypertensive        13(9.9)           61(13.4)            61(15.9)               62(20.7)         197(15.5) 
(>140/90)  
 
  SBP (≥140)          12(9.2)           51(11.2)             42 (11.0)              29 (9.7)           134(10.6) 
 
 




Figure 3 and 4 summarizes the prevalence of hypertension by age groups and gender. The 
prevalence of hypertension increased with age and demonstrated a sharp increase after 35 years, 
both in men and women. For every age group, the age-specific prevalence of hypertension was 




























































Table 9 shows the mean difference of diabetes among groups of hypertensive (≥140/90), systolic 
(≥140), diastolic (≥90) and none hypertensive subjects in men and women. There was a 
significant difference in the trend of diabetes in women within the blood pressure groups 
(p=0.001). The mean difference of blood sugar in women within the blood pressure groups was 
higher than those in men, except for the diastolic blood pressure. However, the total mean of 
blood sugar in women within the blood pressure groups was slightly above that of men 
(5.10±0.98 vs. 5.02±1.46). Again, the blood sugar in the hypertensive and those with high 
systolic blood pressure was high in both genders. Women with hypertension, exhibit a high 
prevalence of diabetes. 
 
Table 9: Mean glucose and standard deviation among hypertensive subjects 








                           20 cases missing 
Variables                   Men (520)       Women (739)          Total 
Hypertensive 
(≥140/90)                   5.18±1.69         5.39±1.56               5.28±1.62     
 
 SBP (≥ 140)               5.12±1.10         5.21± 1.41             5.16±1.25         
 DBP (≥ 90)                5.18±1.36         4.95±0.41               5.06±0.88 
 None hypertensive      4.95±1.47         5.04±0.78             4.99±1.12 








Table 8 shows the relationship, between diabetes and some lifestyles factors. The mean number 
of servings per day of fruits and vegetables was 2.6 for men compared with 2.7 for women. 
Overall, only 42.1% and 57.9% men and women, respectively took > or = 5 servings per day of 
fruits and vegetables. Diabetes was more among those who ate more servings of fruits and 
vegetables. Women were significantly more likely to be physically inactive compared with men 
(23.0% v. 15.1%) (p<0.001); 41.4% of men and 58.6% of women reported mean physical 




   
 
                   
             
                                 
                                                         Prevalence of diabetes  
                                                           within the groups                  
Variables                                    n                    cases              %          
 
Diet intake (%) 
    Vegetable 0-3days/week             746                 72                10.3                  
                     4-7days/week            486                 40                 12.1 
                            
     Fruit       0-3days/week              865                 88                  9.8                                        4-7 days/week            286                 18                  15.8     
  
Physical activity 
                  0-100mins walk/day     1036                93                   9.0                  
                  >100mins walk/day        233                21                   9.0 
Tobacco  
                 Non-smoker                    957                88                   9.2                  
                 Ex-smoker                       228               17                   13.4  
                 Current smoker                 84                 9                    10.7    
  
 
Our findings reveal that those who were employed had a higher prevalence of diabetes than the 
students and the unemployed (p<0.001). Though not significant, there was a difference in the 




income <4 million had a higher prevalence of diabetes (p=0.2). Trend in education and the 
prevalence of diabetes, was not significant, though those with university degree had a lower 
prevalence, as compare to the less educated ones. The married had a higher prevalence, followed 
by the singles then the widow(er) and those cohabiting. There was no significant difference in 
the prevalence of diabetes, in the subgroups (p>0.05).    
 
Table 11: Distribution of FBG by socio­economic class 
       Variables                      cases n                %               p 
 
    Educational level                                                                                                0.7 
         None                                                   24                  291                    21.3 
       Primary                                                 18                  222                    15.9        
        Secondary                                             53                 531                     46.9       
       University                                             18                 219                    16.0 
  
   Yearly income (million/CFA) (%)                                                                       0.2        
       <4 million                                               87               911                    76.3 
      >4 million                                               27               358                    23.7 
  
    Marital status                                                                                                      0.7 
        Single                                                      29                   364                    25.4                                
        Married                                                  71                   746                     62.3   
         Divorced/widow(er)                              13                   136                     11.8 
       Cohabiting                                              1                     19                       0.9 
  
    Occupation                                                                                                                     0.001 
          Unemployed                                          56                   514                  47.3 
         Employed                                              54                   639                   47.4    
          Student                                                   4                    116                   3.5      
 




Age and body mass index status (obesity) remained significant after adjusted for a number of 
possible confounding variables in the multivariate analysis (table 12). Taking age and BMI, the 




having diabetes at the younger age groups (25-35 years) (Table 12). The same thing goes with 
BMI. Those who are obese, have 1.8 times risk of having diabetes than those who are overweight 
and normal in weight. Women have a higher risk of having diabetes than the men, and those 
























Table 12: Multivariate regression models for the relationship between diabetes and some 

























Variables                          cases         n        ORa (95% CI)          p        ORb (95% CI)          p          
 
Sex 
        Male                         45             530    1.00(reference)                     1.00 
        Female                      69            749    1.1(0.72-1.59)        0.70      1.0 (0.7-1.5)            0.9 
 
Age group (years)   
       25-35                       27           553        1.00                          1.00                                                      
       36-45                       22           261        2.0(1.00-3.21)         0.05       2.0 (0.98-3.24)           0.05      
       46-55                       39           257        3.4 (2.08- 5.83)     < 0.001   3.1 (1.8-5.40)        <0.001         
       56+                          26           198        3.0(1.67-5.18)       < 0.001   3.1 (1.70-5.71)      <0.001         
 
Systolic BP                            
       0-140 (mmHg)         76             931      1.00                         1.00 
       ≥140                        35             326       1.3(0.88-2.04)        0.17          1.0 (0.55-1.70)       0.8 
 
 Diastolic BP                           
       0-90 (mmHg)           86           1003    1.00                                        1.00    
       ≥ 90                          25           256      1.2(0.72-1.84)       0.54          1.0 (0.50-1.70)          0.5 
  
BMIc 
       Underweight             7           128         1.0(0.35-2.48)       0.89       0.74 (0.27-2.00)         0.5 
       Normal                     31          455         1.00                                       1.00 
       Overweight               32          381        1.3(0.75-2.09)       0.38       1.1 (0.67-1.91)           0.6 
       Obese                       44           305        2.0(1.26-3.28)      0.004      2.0 (1.06-2.92)           0.02 
 
Waist-hip-ratio 
      Men  
        0-0.9                       66             863       1.00                                     1.00                   
        0.9-0.99                   33             265      2.0(1.10-2.67)      0.01      1.0 (0.55-1.69)            0.9 
         ≥ 1                             15           141     1.4(0.79-2.59)      0.22      1.0 (0.40-1.64)            0.5 
  
Women  
         0-0.80                        14           237    1.00                                         1.00 
         0.80-0.84                   20           271    1.3(0.62-2.5)       0.50           1.2 (0.56-2.40)         0.6    
         ≥ 0.85                         80          761    2.0(1.04-3.36)      0.37          1.4 (0.72-2.82)         0.2 
a crude odd ratio 
b adjusted odd ratio for age, sex, body mass index (BMI), systolic and diastolic blood pressure 
c body mass index (BMI) is defined as body weight (kg)/ height2 
BMI categories: underweight (BMI < 20kg/m2), normal weight (BMI < 25 kg/m2) overweight (BMI 25-29.9 






Some proven and hypothesized risk factors were examined to evaluate their associations with 
type 2 diabetes in Cameroon. Our study reveals that diabetes is uncommon in Cameroon. The 
age- standardized prevalence rate of type 2 diabetes in the study was 9.0%. This is more than 
some prevalent rates reported in some studies in sub-Saharan Africa (52). However, it is 
noteworthy that other cities in Cameroon have a lower rate than in Biyem- Assi, Yaoundé. In the 
current study, women had a significant higher prevalence of diabetes in all age groups (p<0.05). 
Generally, worsening glycaemic status was associated with increasing age, body mass index, 
systolic blood pressure and diastolic blood pressure. The prevalence of impaired fasting Glucose 
in our subjects (6.8%) was similar to that reported in Accra, Ghana (53). 
Documented facts, has well been established that excess body fat is a risk factor for numerous 
chronic conditions such as diabetes, hypertension, hyperlipidaemia and cardiovascular diseases 
(54). Body mass index [BMI, weight (kg)/height (m2)], a measure of relative weight, is a good 
overall indicator of nutritional status and predictor of overall health. 
Studies of anthropometric measures among adult populations of sub-Saharan Africa countries are 
limited and weight, WC, WHR and BMI are the most common indicators which have been used 
to assess overweight and obesity prevalence. As has been suggested (55), increases in the 
prevalence of obesity within a population often precede a rise in the incidence of chronic 
diseases, most notably diabetes and hypertension. 
Body fat was the most important lifestyle indicator for being overweight and obese in both men 
and women. The WHO definition of abdominal obesity and overweight was used, as there is not 
yet a specific definition for Africa population. However, this study highlights the high 
prevalence of overweight and obesity in Cameroon, whether measured by Body Mass Index, 
Waist Circumference or Waist-Hip-Ratio. The prevalence of overweight and obesity estimated 
from this study was particularly high in women, and increased markedly between the ages of 25-
35, 36-45 and >56years in women; and in men between 36-45 and 46-55years (p<0.05). Obesity 




However, the prevalence of obesity, estimated from this study is consistent with already 
published results. Sobngwi et al in 2002 reported a prevalence of BMI obesity of 5.4% in men 
and 17.1% in women among Cameroonian adult, which is lower than found in this study. 
Nevertheless, lower prevalence’s have been reported in urban settings in Africa (56), and a much 
higher prevalence 42% in women and a prevalence of 9.2% in men in Tanzania(57) 
Obesity as estimated by BMI (measures of total body fat) and central obesity, as estimated by 
WC and WHR was lower among men in younger age group (5.0-10.0) and high among women 
(23.7-40.8). BMI defined obesity increased to 10.5 in 36-45 years old men and remain fairly 
constant in the older age groups, while central obesity measures by WHR continue to increase to 
a maximum of 27.1 in >56 years group. BMI defined obesity increased to a peak of 49.7 in the 
46-55 years group in women and increased steadily across all age groups to a maximum of 
75.3% in women greater than 56 years of age. 
The findings of this study accords with what has been known about obesity and diabetes, 
mentioning obesity as being so far the strongest modifiable risk factor for type 2 diabetes(58). 
Independent of gender, in this study, subjects with BMI ≥25kg/m2 and WHR of ≥0.85 were at a 
significant higher risk of having type 2 diabetes (p<0.05). Epidemiological studies, have 
demonstrated this effect on diabetes. Overweight and obesity emerged as a strong independent 
risk factor for diabetes, irrespective of the measure used.  
The WHO definition uses a higher cutpoint for waist circumference for men and women, this is 
probably not suitable in our population, where the mean waist circumference in women is greater 
than that of men. This may explain the higher prevalence of abdominal obesity in women than 
the men. Therefore results from this study indicate that weight gain is an important risk factor for 
hyperglycemia. Therefore control of body weight is the most effective way to reduce the risk of 
type 2 diabetes. The public usually do not recognize the connection between overweight or 
obesity and diabetes(59). Thus education should be use as a strategy to create awareness. 
In Cameroon, hypertension has been showed to be about 1.5-3 fold more prevalent in those with 
diabetes compared to the general population, either in hospital or community- based. Our 




high blood pressure, has a higher risk of having higher blood sugar level than the normal 
population. The association in this study is probably associated with obesity. Study in Trinidad 
(60) found that newly diagnosed type 2 diabetic patients have an increased risk of cardiovascular 
diseases. 
In the present study, the effects of non modifiable risk factors like age and sex on diabetes were 
analyzed. Age was a significant risk factor for diabetes, even after adjusting for confounding 
factors. The older age groups (46-55 and 56+) had twice and thrice the risk of having diabetes, 
than the younger and the normal population (adjusted OR=3.1, p<0.001). Therefore our finding 
shows that with an increase of ten years in age, you have a higher risk than a younger person. 
Though sex was not significant, our findings found women having a higher risk of diabetes than 
the men. This may be because women were obese than the men (p<0.001), and had a higher risk 
of having diabetes than the men. Our findings reveal a correlation between the anthropometric 
measurements, but not with WHR. WHR was negatively correlated with HC. There was a 
correlation between body mass index and sex in this study (r=0.21, p<0.001). Numbers of studies 
have repeatedly shown an association, between trends with age and gender difference with 
diabetes (61). I very well know that we cannot stop the process of aging in our population, as 
well as interchanging gender. Since these risk factors cannot be changed, screening of the 
population especially at a much younger age and those at a higher risk of having diabetes will be 
a good measure in the prevention and control of diabetes. (Emphasis should be more on those 
with higher risk of diabetes). 
Modifiable risk factors, like lifestyle factors affect the incidence of type 2 diabetes. Our findings 
did not identify physical inactivity as the risk factor to type 2 diabetes, but shows that those who 
were physically inactive had a higher prevalence and a higher risk of having diabetes than those 
who were physically active (adjusted OR= 1.1, 95% CI (0.65-1.80). This was the same with 
yearly income. Those with a higher yearly income had a higher prevalence of diabetes. We also 
found that, they are at a higher risk (adjusted OR=1.3, 95% CI (0.84-2.10) compare to those who 
had lesser income. However, both cross-sectional and longitudinal studies, have found physical 
activity and socio-economic status as independent predictors for obesity and type 2 diabetes (62-




well as treatment for type 2 diabetes and other chronic non- communicable diseases. Smoking 
and dietary factors were other risk factors analyzed in the current study. Prevalence of diabetes 
was 15.8 vs. 9.8 in those who ate fruits 4-7 days/week and 0-3 days/week, respectively. For those 
who ate vegetables, the prevalence of diabetes was (12.1 vs. 10.3), in the same order as those 
who ate fruits, indicating that diabetes was more in those who ate more servings of fruits and 
vegetables. Since a lot of palm oil is used in Cameroon cuisine, there is a probability that they 
used a lot of palm oil in cooking their vegetables, which in effect will increase their weight, 
therefore making them prone to diabetes. In the other hand, eating more fruits, means consuming 
more sugar. This may in other sense, explain why those who ate more servings of fruits had 
diabetes, as compare to those who ate lesser servings of fruits. Ex-smokers as compare to current 
smokers had a higher prevalence of type 2 diabetes (13.4 vs. 10.7), but without an association 
with diabetes.  
However, looking at type 2 diabetes, our current study observed that obesity and weight gain 
dramatically increase the risk, and physical inactivity further elevates the risk, independently of 
obesity.  Though our study did not unveil the association of physical activity and smoking to be 
associated with diabetes, it has been clear from large number of epidemiological studies that 
Cigarette smoking is associated with a small increase and moderate alcohol consumption with a 
decrease in the risk of diabetes. Furthermore low-fiber diet with a high glycemic index has been 
associated with an increased risk of diabetes and specific dietary fatty acids may differently 
affect insulin resistance and the risk of diabetes(65-67). The probability of having type 2 
diabetes in this study is strongly dependent on age.  
Our findings may be compared with population based studies in rural and urban Africa. A study 
in southern Sierra Leone found a 2.4% prevalence of diabetes (68), which was lower than what 
we found in the current study. This study had a smaller sample size. Teuschera et al found no 
cases of diabetes in a survey in West Africa (69), while Fisch et al found 0.9% in Mali (70). 
None of these studies used official diagnostic criteria (WHO or ADA) for diagnosis. Again they 
used reflectance meters in the field which always give inaccurate results, except proper quality 







Non-communicable diseases have modifiable risk factors, which are easy to measure and can 
help in planning effective interventions. However, there is now substantial evidence that type 2 
diabetes can be prevented or delayed. Individuals at high risk of developing diabetes can be 
identified easily. It is not yet known whether successful interventions will cost-effectively reduce 
the morbidity and mortality associated with diabetes. However, diabetes prevention policies that 
focus on lifestyle modification, specifically modest weight loss and increased physical activity, 
are very likely to have additional health benefits. Therefore, public health messages, health care 
professionals, and health care systems should all encourage behavior changes to achieve a 
healthy lifestyle. Further research is necessary to understand better on how to facilitate effective 
and efficient programs for the primary prevention of type 2 diabetes. Nonetheless, it is possible 





In general, the main strength of the study started with the quality assurance during recruitment of 
the quality field data collection staffs, piloting of the tools and quality assurance measures taken. 
Accuracy of the anthropometric measurements by the quality staffs is likely to have increased 
reliable data and results. Repeatability of the anthropometric measurements was emphasized 
during training, therefore, three measurements were taken and the mean value of the three was 
used for analysis. Refresher trainings were provided twice in the field to assure that the standards 
were up to date. Crosschecking and validating forms and data entry was as well a quality 





The rigorous cold chain maintained during the movement of the Microcuvet Haemocues, which 
is actually wet chemistry for obtaining fasting blood glucose, was a major quality measure for 
authentic data. 
The fact that the study was population base, the result of the current study may lay the 
foundation to develop policies necessary to cope with the challenges of diabetes mellitus. 
The large sample size (1279), though not up to the calculated sample size, however met the 
requirement of the analysis. We detected a high prevalence of diabetes than presumed. 
Most confounding factors were controlled for like sex, age, body mass index etc using 
multivariate analysis (logistic regression) and partial correlation coefficient. 
Not many study of this kind, has been done in Africa, so the result will be use as a reference 
data, especially in Cameroon and sub- Saharan Africa in general. 
In addition, I am well known in this population, so some local volunteer in this population help, 
by making sure that the participants did not eat prior to testing for fasting blood glucose, thus 
increasing the reliability of the data and result. 
 
5.2 Limitation of the study 
The cross sectional nature of this study, was a major limitation. The cross sectional nature limits 
the causal interference between exposure and disease outcome. 
Selection bias: bias in a sense is a systematic deviation from the truth, which has potential impact 
on the quality of the data. Only one health district was selected in the study area.  
Recall bias was again a limitation. We had none responses, because participants could not 
remember the time they spend on physical activity and servings of fruits and vegetables eaten in 
a day. 
Interview challenges: observer bias may exist in our study. Self reported questionnaires, may 




interviewer and in the interpretation of any reply. In our study, interviewers were train on how to 
use field guidelines for presentation of materials in a similar manner. 
Our results may reflect some problem of statistical power, because of small number of 























The study provides current data on diabetes mellitus, anthropometric measurements and obesity 
in urban Cameroonian populations. We found high occurrence of diabetes mellitus and impaired 
fasting glycaemia, high occurrence of obesity and that high proportion of women have diabetes 
mellitus and obesity particularly over 35 years of age. Prevalence of obesity varied according to 
the measures used. Our findings therefore highlight the need to adopt policies to reduce the 
burden of diabetes mellitus and obesity through health care services; special focus should be 
projected to women and special care should be taken for those who are in transition of lifestyle.  
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